“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In Part ...

When pooling five multi-ethnic US longitudinal studies with average follow-up of 21 years, there was graded association of Lp(a) with ASCVD events. Compared to those below the 50th percentile (median ...

The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) due to long-term ...

SGLT2i reduce the risk of MACE across a broad range of patient populations and key subgroups. The primary benefit of SGLT2i for MACE is driven by a reduction in CV death mediated primarily by a ...

The presence of cardiomyopathy-associated predicted deleterious variants is associated with an increased risk for all-cause mortality, clinical diagnosis of cardiomyopathy, and composite ...

It's becoming increasingly evident that alongside top-notch clinical expertise, the CV specialist of the future must be surrounded by a multi-talented, diverse team to provide optimal patient care. In ...

The following are key points to remember from a review comparing contemporary clinical practice recommendations for the management of heart failure (HF) in the American and European guidelines: ...

The American College of Cardiology has recognized the 2024 winners of its Young Investigator Awards at the American College of Cardiology’s Annual Scientific Session (ACC.24). The Young Investigator ...

Mitral annular calcification (MAC) is common in the setting of chronic kidney disease and aging. Previously presumed "degenerative" in etiology, cardiac/vascular calcification is now understood to be ...

Szarek M, Bhatt DL, Miller M, et al., on behalf of the REDUCE-IT Investigators. Data from REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) were used for the ...

Leiva O, Alviar C, Khandhar S, et al. The investigators identified patients hospitalized with intermediate-risk or high-risk PE using the 2017-20 National Readmission Database. In-hospital outcomes ...